PDMR Dealings
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Joe Wiley
| ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status | CEO
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Amryt Pharma plc
| ||||
b) | LEI | 213800YNUJEOJ8L4T95
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.06 each
GB00BKLTQ412
| ||||
b) | Nature of the transaction | Purchase of Shares
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
7,999 shares
£9,750.78
| ||||
e) | Date of the transaction | January 7th, 2020
| ||||
f) | Place of the transaction | London Stock Exchange, AIM
| ||||
g) | Additional Information |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.